Cargando…

Progress in Cardiac Resynchronisation Therapy and Optimisation

Cardiac resynchronisation therapy (CRT) has become the cornerstone of heart failure (HF) treatment. Despite the obvious benefit from this therapy, an estimated 30% of CRT patients do not respond (“non-responders”). The cause of “non-response” is multi-factorial and includes suboptimal device setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Zaki, Gallagher, Mark M., Kontogiannis, Christos, Leung, Lisa W. M., Spartalis, Michael, Jouhra, Fadi, Sohal, Manav, Shanmugam, Nesan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607614/
https://www.ncbi.nlm.nih.gov/pubmed/37887875
http://dx.doi.org/10.3390/jcdd10100428
Descripción
Sumario:Cardiac resynchronisation therapy (CRT) has become the cornerstone of heart failure (HF) treatment. Despite the obvious benefit from this therapy, an estimated 30% of CRT patients do not respond (“non-responders”). The cause of “non-response” is multi-factorial and includes suboptimal device settings. To optimise CRT settings, echocardiography has been considered the gold standard but has limitations: it is user dependent and consumes time and resources. CRT proprietary algorithms have been developed to perform device optimisation efficiently and with limited resources. In this review, we discuss CRT optimisation including the various adopted proprietary algorithms and conduction system pacing.